{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1146.1049","meta":{"versionId":"11","lastUpdated":"2019-12-27T01:00:20.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CSTE Author"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-keyWord","valueString":"Parkinson,Trigger"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2019-12-27"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1049","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1146.1049"}],"version":"20191227","name":"ParkinsonismSecondaryICD10CM","title":"Parkinsonism [Secondary] (ICD10CM)","status":"active","experimental":false,"date":"2019-12-27T01:00:20-05:00","publisher":"CSTE Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains diagnoses or problems that represent that the patient has secondary Parkinson's regardless of the clinical presentation of the condition),(Data Element Scope: Diagnoses or problems documented in a clinical record.),(Inclusion Criteria: Root1 = Secondary Parkinsonâ€™s disease and children),(Exclusion Criteria: None)","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"A52.19","display":"Other symptomatic neurosyphilis"},{"code":"G21","display":"Secondary parkinsonism"},{"code":"G21.1","display":"Other drug-induced secondary parkinsonism"},{"code":"G21.11","display":"Neuroleptic induced parkinsonism"},{"code":"G21.19","display":"Other drug induced secondary parkinsonism"},{"code":"G21.2","display":"Secondary parkinsonism due to other external agents"},{"code":"G21.3","display":"Postencephalitic parkinsonism"},{"code":"G21.4","display":"Vascular parkinsonism"},{"code":"G21.8","display":"Other secondary parkinsonism"},{"code":"G21.9","display":"Secondary parkinsonism, unspecified"}]}]},"expansion":{"identifier":"urn:uuid:cebd4fb7-9f9f-4931-afcf-fd8c62e3a146","timestamp":"2023-12-10T21:50:52-05:00","total":10,"contains":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"A52.19","display":"Other symptomatic neurosyphilis"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21","display":"Secondary parkinsonism"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21.1","display":"Other drug-induced secondary parkinsonism"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21.11","display":"Neuroleptic induced parkinsonism"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21.19","display":"Other drug induced secondary parkinsonism"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21.2","display":"Secondary parkinsonism due to other external agents"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21.3","display":"Postencephalitic parkinsonism"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21.4","display":"Vascular parkinsonism"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21.8","display":"Other secondary parkinsonism"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"G21.9","display":"Secondary parkinsonism, unspecified"}]}}